Cape Investment Advisory, Inc.

Position in JNJ — Johnson & Johnson

CIK 1944437 MCDONOUGH, GA

Position in JNJ

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$731,432

+$76,578 QoQ

Shares Held

2,880

+7.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.52%

of 13F equity value

Holder Rank

#3,324

of 4,676 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cape Investment Advisory, Inc. holds $3,326,940 across 15 Drug Manufacturers - General names. JNJ ranks #1 (22.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	2,880	$731,432
2	LLY	ELI LILLY & Co	464	$556,535
3	GSK	GSK plc	9,228	$483,731
4	ABBV	AbbVie Inc.	1,417	$356,573
5	MRK	Merck & Co., Inc.	2,665	$342,452
6	PFE	Pfizer Inc	12,694	$305,671
7	AMGN	Amgen Inc	631	$228,497
8	NVS	Novartis AG	747	$117,069

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$731,432	2,880	+7.5%	Shares	Sole	2026-07-23
2026-03-31	$654,854	2,679	-4.9%	Shares	Sole	2026-05-15
2025-12-31	$583,185	2,818	+257.2%	Shares	Sole	2026-02-17
2025-09-30	$146,296	789	-72.3%	Shares	Sole	2025-12-29
2025-06-30	$434,421	2,844	-0.0%	Shares	Sole	2025-08-19
2025-03-31	$471,814	2,845	-9.5%	Shares	Sole	2025-05-16
2024-12-31	$454,396	3,142	-20.8%	Shares	Sole	2025-02-05
2024-09-30	$642,567	3,965	-2.3%	Shares	Sole	2024-11-14
2024-06-30	$592,971	4,057	-12.1%	Shares	Sole	2024-08-15
2024-03-31	$729,730	4,613	-3.3%	Shares	Defined	2024-06-21
2023-12-31	$747,493	4,769	+6.9%	Shares	Sole	2024-02-12
2023-09-30	$694,956	4,462	-21.1%	Shares	Defined	2023-11-07
2023-06-30	$936,181	5,656	+5.1%	Shares	Defined	2023-10-12
2023-03-31	$833,900	5,380	—	Shares	Defined	2023-10-12
No filing history on record for this holder in this stock.